Table 2.
Clinicopathologic parameters of patients with malignant melanoma from the datasets GSE15605 and GSE19234.
| Characteristics | GSE15605 | GSE19234 | ||
|---|---|---|---|---|
| Normal | Primary | Metastatic | ||
| Gender | ||||
| Male | 13 (81.2%) | 32 (69.6%) | 6 (50%) | 28 (63.6%) |
| Female | 3 (18.8%) | 14 (30.4%) | 6 (50%) | 16 (36.4%) |
| Age (years) | ||||
| ≥60 | 5 (31.2%) | 23 (50%) | 6 (50%) | 19 (43.2%) |
| <60 | 11 (68.8%) | 23 (50%) | 6 (50%) | 25 (56.8%) |
| Diagnosis | ||||
| Superficial spreading melanoma | 28 (60.9%) | 8 (66.7%) | ||
| Desmoplastic melanoma | 1 (2.2%) | 2 (16.7%) | ||
| Acral lentiginous melanoma | 3 (6.5%) | 2 (16.7%) | ||
| Mucosal melanoma | 0 | 0 | ||
| Lentigo maligna melanoma | 1 (2.2%) | 0 | ||
| Nodular melanoma | 8 (17.4%) | 0 | ||
| Other types | 5 (10.9%) | 0 | ||
| Mutation | ||||
| WT | ||||
| BRAF | 20 (43.5%) | 8 (66.7%) | ||
| NRAS | 6 (13.0%) | 2 (16.7%) | ||
| Stage | ||||
| IIIA | 4 (9.0%) | |||
| IIIB | 23 (52.3%) | |||
| IIIC | 12 (27.3%) | |||
| IV | 5 (11.4%) | |||
BRAF: V-RAF murine sarcoma viral oncogene homolog B1; NRAS: neuroblastoma-rat sarcoma viral oncogene homolog.